Mitchell W. Krucoff

Active 1986–2025

122
Papers
34,246
Citations
77
h-index
115
i10-index

Citations

Citations per year for Mitchell W. Krucoff1947: 1 citations1987: 1 citations1988: 2 citations1989: 2 citations1990: 7 citations1991: 7 citations1993: 12 citations1994: 4 citations1995: 15 citations1996: 16 citations1997: 11 citations1998: 25 citations1999: 16 citations2000: 28 citations2001: 29 citations2002: 18 citations2003: 26 citations2004: 30 citations2005: 33 citations2006: 26 citations2007: 42 citations2008: 66 citations2009: 88 citations2010: 92 citations2011: 168 citations2012: 258 citations2013: 222 citations2014: 198 citations2015: 294 citations2016: 292 citations2017: 236 citations2018: 225 citations2019: 860 citations2020: 1,043 citations2021: 881 citations2022: 630 citations2023: 520 citations2024: 886 citations2025: 409 citations2026: 22 citations1948–1986: no citations, so these years are not shown1992: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,627 citing papers, 18.5% of this breakdownItaly: 1,087 citing papers, 7.7% of this breakdownGermany: 1,032 citing papers, 7.3% of this breakdownUnited Kingdom: 1,023 citing papers, 7.2% of this breakdownNetherlands: 782 citing papers, 5.5% of this breakdownFrance: 678 citing papers, 4.8% of this breakdownCanada: 669 citing papers, 4.7% of this breakdownSwitzerland: 544 citing papers, 3.8% of this breakdownJapan: 501 citing papers, 3.5% of this breakdownSpain: 483 citing papers, 3.4% of this breakdownChina: 466 citing papers, 3.3% of this breakdownBelgium: 372 citing papers, 2.6% of this breakdown
0%18.5%Other 27.7%

Fields

  • Medicine92.5%
  • Engineering3.1%
  • Biochemistry, Genetics and Molecular Biology1.1%
  • Computer Science0.6%
  • Economics, Econometrics and Finance0.6%
  • Health Professions0.4%
  • Other1.7%

Topics

  • Coronary Interventions and Diagnostics11.8%
  • Acute Myocardial Infarction Research8.9%
  • Cardiac Imaging and Diagnostics7.3%
  • Antiplatelet Therapy and Cardiovascular Diseases7.1%
  • Cardiac Valve Diseases and Treatments6.4%
  • Atrial Fibrillation Management and Outcomes4.1%
  • Other54.4%

Coauthors

All papers

Open in search
  1. Standardized Bleeding Definitions for Cardiovascular Clinical Trials

    Authors: , , , , , , , , , , , , , , , , , , , - Circulation 2011 cited by 4,423

  2. Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus Document

    Authors: , , , , , , , , , , , , , , , , , - Circulation 2018 cited by 933

  3. Clinical End Points in Coronary Stent Trials

    Authors: , , , , , , , , , , , , , , - Circulation 2007 cited by 5,420

  4. Outcomes of Anatomical versus Functional Testing for Coronary Artery Disease

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 cited by 1,506

  5. Ticagrelor with or without Aspirin in High-Risk Patients after PCI

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philippe Gabríel Steg, Giora Weisz, Bernhard Witzenbichler, Yaling Han, Stuart Pocock, C. Michael Gibson - New England Journal of Medicine 2019 cited by 1,000

  6. Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ute Windhoevel, Robert W. Yeh, Mitchell W. Krucoff, Marie-Claude Morice - Circulation 2019 cited by 796

  7. Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ute Windhoevel, Robert W. Yeh, Mitchell W. Krucoff, Marie-Claude Morice - European Heart Journal 2019 cited by 572

  8. Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philippe Gabríel Steg, Robert F. Storey, Jurriën M. ten Berg, Marco Valgimigli, Pascal Vranckx, Hirotoshi Watanabe, Stephan Windecker, Patrick W. Serruys, Robert W. Yeh, Marie‐Claude Morice, Dominick J. Angiolillo - Circulation 2023 cited by 165

  9. Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 cited by 1,898

  10. Standardized Definitions for Cardiogenic Shock Research and Mechanical Circulatory Support Devices: Scientific Expert Panel From the Shock Academic Research Consortium (SHARC)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Circulation 2023 cited by 174

  11. Updated Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2012 cited by 1,662

  12. Definitions and Clinical Trial Design Principles for Coronary Artery Chronic Total Occlusion Therapies: CTO-ARC Consensus Recommendations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William J. Nicholson, Yoshinobu Onuma, Georgios Sianos, Satoru Sumitsuji, Etsuo Tsuchikane, Renu Virmani, Simon Walsh, Gerald S. Werner, Masahisa Yamane, Gregg W. Stone, Stéphane Rinfret, Gregg W. Stone - Circulation 2021 cited by 290

  13. Standardized End Point Definitions for Coronary Intervention Trials

    Authors: , , , , , , , , , , , , , , , , , - European Heart Journal 2018 cited by 311

  14. Evaluation and Treatment of Patients With Lower Extremity Peripheral Artery Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2015 cited by 367

  15. Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Philippe Gabríel Steg, Giora Weisz, Bernhard Witzenbichler, Yaling Han, Stuart Pocock, C. Michael Gibson, Roxana Mehran - European Heart Journal 2020 cited by 176

  16. Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents

    Authors: , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2016 cited by 548

  17. Radial Versus Femoral Access for Coronary Interventions Across the Entire Spectrum of Patients With Coronary Artery Disease

    Authors: , , , , , , , , , , , - JACC: Cardiovascular Interventions 2016 cited by 517

  18. Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ernest Spitzer - Circulation 2022 cited by 74

  19. Validation of the Academic Research Consortium High Bleeding Risk Definition in Contemporary PCI Patients

    Authors: , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2020 cited by 217

  20. Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , - European Journal of Heart Failure 2020 cited by 92

  21. Standardized Endpoint Definitions for Transcatheter Aortic Valve Implantation Clinical Trials

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2011 cited by 734

  22. Practice Standards for Electrocardiographic Monitoring in Hospital Settings

    Authors: , , , , , , , , , - Circulation 2004 cited by 621

  23. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium

    Authors: , , , , , , , , , , , , , , , , , , , - European Heart Journal 2011 cited by 1,217

  24. Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of the American College of Cardiology 2021 cited by 75